CSIMarket


Aclaris Therapeutics Inc   (NASDAQ: ACRS)
Other Ticker:  
 

Aclaris Therapeutics Inc

ACRS's Fundamental analysis








Aclaris Therapeutics Inc 's sales fell by -47.58 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 3217

Major Pharmaceutical Preparations industry recorded growth of revenues by 11.85 %

Aclaris Therapeutics Inc net loss increased from $-1 millions, to $-97 millions in IV. Quarter 2024,

More on ACRS's Growth


Aclaris Therapeutics Inc
realized a net loss in trailing twelve months.

Aclaris Therapeutics Inc realized cash reduction of $ -0.2 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.53.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.


More on ACRS's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 205,714
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 55.1
 Tangible Book Value (Per Share $) 2.01

Aclaris Therapeutics Inc
realized net loss in trailing twelve months.

Aclaris Therapeutics Inc realized cash outflow of $ -0.2per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.53.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.

Aclaris Therapeutics Inc Price to Book Ratio is at 0.67 lower than Industry Avg. of 79.76. and higher than S&P 500 Avg. of 0.01

More on ACRS's Valuation

  Market Capitalization (Millions $) 103
  Shares Outstanding (Millions) 77
  Employees 91
  Revenues (TTM) (Millions $) 19
  Net Income (TTM) (Millions $) -132
  Cash Flow (TTM) (Millions $) -15
  Capital Exp. (TTM) (Millions $) -36
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 205,714
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 55.1
  Tangible Book Value (Per Share $) 2.01

  Market Capitalization (Millions $) 103
  Shares Outstanding (Millions) 77
  Employees 91
  Revenues (TTM) (Millions $) 19
  Net Income (TTM) (Millions $) -132
  Cash Flow (TTM) (Millions $) -15
  Capital Exp. (TTM) (Millions $) -36





  Ratio
   Capital Ratio (MRQ) 3.99
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.42
  Asset Turnover Ratio (TTM) 0.1
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com